Skip to main content
. Author manuscript; available in PMC: 2010 Feb 25.
Published in final edited form as: AIDS Care. 2008 Nov;20(10):1161–1168. doi: 10.1080/09540120701855375

Table 2.

Hypothetical HIV vaccine attributes.

Vaccine attributes

HIV Vaccine number Efficacy (%) Side-effects Duration of protection Doses Route Protection (cross-clade) Cost ($)
1 50 None 1 year 4 Injection Multiple types 0
2 99 None 1 year 1 Oral Multiple types 250
3 50 Minor 1 year 1 Injection One type 250
4 99 Minor 1 year 4 Oral One type 0
5 50 None 10 years 4 Oral One type 250
6 99 None 10 years 1 Injection One type 0
7 50 Minor 10 years 1 Oral Multiple types 0
8 99 Minor 10 years 4 Injection Multiple types 250